“Fed Proof” Your Bank Account with THESE 4 Simple Steps

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.

Mark Ziebell Biography and Net Worth

General Counsel of Avid Bioservices

Mark Ziebell has served as Vice President and General Counsel since June 2012. Prior to joining the organization, Mr. Ziebell was a Partner at Snell & Wilmer LLP, a law firm based in Orange County, California where his practice specialized in securities law, mergers and acquisitions, corporate governance and general corporate law representing companies in a broad range of industries including the biopharmaceutical and technology sectors. Prior to Snell & Wilmer, he was a Partner at the law firm of Falk, Shaff & Ziebell where he was part of the Corporate and Securities practice area. Prior to that Mr. Ziebell has held positions of increasing responsibility within the accounting and legal sectors.

Mr. Ziebell holds a JD degree from the University of San Francisco, School of Law and a BA in Accounting from the University of San Francisco.

What is Mark R. Ziebell's net worth?: The estimated net worth of Mark R. Ziebell is at least $787,084.76 as of April 30th, 2024. Mr. Ziebell owns 64,834 shares of Avid Bioservices stock worth more than $787,085 as of November 17th. This net worth estimate does not reflect any other investments that Mr. Ziebell may own. Additionally, Mr. Ziebell receives a salary of $477,160.00 as General Counsel at Avid Bioservices. Learn More about Mark R. Ziebell's net worth.
How old is Mark R. Ziebell?: Mr. Ziebell is currently 60 years old. There are 4 older executives and no younger executives at Avid Bioservices. Learn More on Mark R. Ziebell's age.
What is Mark R. Ziebell's salary?: As the General Counsel of Avid Bioservices, Inc., Mr. Ziebell earns $477,160.00 per year. There are 2 executives that earn more than Mr. Ziebell. The highest earning executive at Avid Bioservices is Mr. Nicholas Stewart Green B.Sc., MBA, President, CEO & Director, who commands a salary of $699,010.00 per year. Learn More on Mark R. Ziebell's salary.
How do I contact Mark R. Ziebell?: The corporate mailing address for Mr. Ziebell and other Avid Bioservices executives is 2642 Michelle Drive Suite 200, TUSTIN CA, 92780. Avid Bioservices can also be reached via phone at (714) 508-6100 and via email at [email protected]. Learn More on Mark R. Ziebell's contact information.
Has Mark R. Ziebell been buying or selling shares of Avid Bioservices?: Mark R. Ziebell has not been actively trading shares of Avid Bioservices in the last ninety days. Most recently, Mark R. Ziebell sold 1,643 shares of the business's stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $7.40, for a transaction totalling $12,158.20. Following the completion of the sale, the general counsel now directly owns 64,834 shares of the company's stock, valued at $479,771.60. Learn More on Mark R. Ziebell's trading history.
Who are Avid Bioservices' active insiders?: Avid Bioservices' insider roster includes Mark Bamforth (Director), Nicholas Green (CEO), Richard Hancock (Director), Daniel Hart (CFO), and Mark Ziebell (General Counsel). Learn More on Avid Bioservices' active insiders.
Are insiders buying or selling shares of Avid Bioservices?: In the last twelve months, Avid Bioservices insiders bought shares 1 times. They purchased a total of 23,000 shares worth more than $134,780.00. In the last twelve months, insiders at the biopharmaceutical company sold shares 15 times. They sold a total of 50,858 shares worth more than $423,264.89. The most recent insider tranaction occured on October, 14th when insider Matthew R Kwietniak sold 119 shares worth more than $1,207.85. Insiders at Avid Bioservices own 3.1% of the company. Learn More about insider trades at Avid Bioservices.
Information on this page was last updated on 10/14/2024.

Mark R. Ziebell Insider Trading History at Avid Bioservices

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/30/2024	Sell	1,643	$7.40	$12,158.20	64,834
1/10/2024	Sell	1,346	$6.17	$8,304.82	63,269
10/10/2023	Sell	1,141	$9.20	$10,497.20	60,515
7/10/2023	Sell	687	$13.77	$9,459.99	49,173
6/29/2023	Sell	2,377	$12.70	$30,187.90	48,255
5/1/2023	Sell	25,000	$17.91	$447,750.00	40,119
4/10/2023	Sell	736	$19.80	$14,572.80	40,119
1/10/2023	Sell	1,150	$14.44	$16,606.00	38,897
4/11/2022	Sell	368	$18.56	$6,830.08	8,103
3/21/2022	Sell	1,974	$22.03	$43,487.22
3/18/2022	Sell	1,302	$22.01	$28,657.02
2/10/2022	Sell	6,429	$22.14	$142,338.06
1/10/2022	Sell	351	$21.58	$7,574.58
1/3/2022	Sell	20,675	$27.65	$571,663.75
12/27/2021	Sell	6,829	$30.27	$206,713.83
12/15/2021	Sell	6,429	$24.57	$157,960.53
10/11/2021	Sell	349	$22.37	$7,807.13
7/12/2021	Sell	7,207	$25.61	$184,571.27
7/13/2020	Sell	3,683	$6.88	$25,339.04	10,512

Mark R. Ziebell Buying and Selling Activity at Avid Bioservices

Avid Bioservices Company Overview

Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. It provides process development and current good manufacturing practice clinical and commercial manufacturing services of biologics, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, regulatory submission and support, upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization services. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is based in Tustin, California.

Today's Range

Now: $12.14

$12.02

$12.17

50 Day Range

MA: $10.85

$8.95

$12.45

2 Week Range

Now: $12.14

$4.07

$12.48

Volume

3,576,492 shs

Average Volume

3,428,059 shs

Market Capitalization

$774.41 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.4

“Fed Proof” Your Bank Account with THESE 4 Simple Steps

From Weiss Ratings | Ad

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.

Mark Ziebell Biography and Net Worth

What is Mark R. Ziebell's net worth?

How old is Mark R. Ziebell?

What is Mark R. Ziebell's salary?

How do I contact Mark R. Ziebell?

Has Mark R. Ziebell been buying or selling shares of Avid Bioservices?

Who are Avid Bioservices' active insiders?

Are insiders buying or selling shares of Avid Bioservices?